Do you have the same question? Follow this Question
Oct 23, 2025 - 11:07 AM
We’ve provided several answers to questions related to Entyvio (Vedolizumab) , see some other helpful Q&A related to this product.
Question: What is the pregnancy recommendation for this medication?
Answer: If you are pregnant or planning to become pregnant, you should consult your doctor before using this medication. Consulting a healthcare professional ensures the safety of both mother and baby when considering treatment options.
Question: What is the DrugBank identification number for vedolizumab?
Answer: The DrugBank ID is DB09033. DrugBank IDs are useful for referencing detailed pharmacological data in scientific databases.
Question: What is the protein binding percentage of vedolizumab?
Answer: The protein binding is approximately 98%. High protein binding indicates a longer duration in the body, which helps maintain therapeutic levels over time.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is vedolizumab. Vedolizumab is a monoclonal antibody designed to target inflammation in the gut, which is valuable for those seeking targeted therapy for conditions like ulcerative colitis and Crohn’s disease.
